Squarepoint Ops LLC Raises Stock Holdings in Option Care Health, Inc. $OPCH

Key Points

• Squarepoint Ops LLC increased its Option Care Health stake by 234.1% in the second quarter, adding 304,376 shares to own 434,408 shares valued at approximately $9.1 million.
• Option Care Health exceeded quarterly expectations, reporting $0.45 in adjusted EPS versus a $0.43 consensus estimate and $1.44 billion in revenue, up 1.9% year over year.
• Analyst sentiment remains mixed: the stock has a consensus “Hold” rating and a $29.92 price target, while several firms recently lowered targets and Weiss Ratings downgraded the shares to “sell.”

Squarepoint Ops LLC grew its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 234.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 434,408 shares of the company's stock after acquiring an additional 304,376 shares during the quarter. Squarepoint Ops LLC owned about 0.29% of Option Care Health worth $9,110,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of OPCH. Royal Bank of Canada grew its position in Option Care Health by 20.7% during the 1st quarter. Royal Bank of Canada now owns 231,161 shares of the company's stock worth $8,078,000 after purchasing an additional 39,661 shares during the last quarter. AQR Capital Management LLC raised its holdings in shares of Option Care Health by 162.6% in the first quarter. AQR Capital Management LLC now owns 41,633 shares of the company's stock valued at $1,450,000 after buying an additional 25,777 shares during the last quarter. Empowered Funds LLC acquired a new stake in shares of Option Care Health during the first quarter worth about $208,000. Invesco Ltd. boosted its stake in shares of Option Care Health by 2.7% during the second quarter. Invesco Ltd. now owns 294,363 shares of the company's stock worth $9,561,000 after buying an additional 7,678 shares during the period. Finally, EverSource Wealth Advisors LLC grew its holdings in shares of Option Care Health by 528.1% during the second quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company's stock worth $46,000 after buying an additional 1,183 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $23.63 on Friday. The company has a quick ratio of 0.98, a current ratio of 1.47 and a debt-to-equity ratio of 0.91. The company has a market cap of $3.54 billion, a P/E ratio of 17.77, a PEG ratio of 1.37 and a beta of 0.61. Option Care Health, Inc. has a 52 week low of $18.01 and a 52 week high of $36.80. The company has a 50-day moving average price of $23.00 and a 200 day moving average price of $24.46.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $0.45 earnings per share for the quarter, beating analysts' consensus estimates of $0.43 by $0.02. The company had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.42 billion. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The firm's revenue for the quarter was up 1.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.41 EPS. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Research analysts predict that Option Care Health, Inc. will post 1.69 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages recently issued reports on OPCH. Stephens restated an "equal weight" rating and issued a $24.00 price target (down from $30.00) on shares of Option Care Health in a research report on Friday, July 17th. The Goldman Sachs Group initiated coverage on Option Care Health in a research note on Monday, June 8th. They issued a "neutral" rating and a $22.00 target price on the stock. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and issued a $24.00 target price (down from $26.00) on shares of Option Care Health in a report on Thursday, July 30th. Weiss Ratings cut Option Care Health from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Thursday, August 27th. Finally, Zacks Research raised Option Care Health from a "strong sell" rating to a "hold" rating in a report on Monday, July 6th. Seven analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $29.92.

Option Care Health Profile

Option Care Health NASDAQ: OPCH is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses.

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.